Skip to main content
. 2021 Aug 24;47(11):696–703. doi: 10.1016/j.jcjq.2021.08.011

Table 3.

Characteristics of the Index Admission in Patients with Preventable and Nonpreventable Revisits

Characteristic Preventable (n = 20) Nonpreventable (n = 56) p value
Revisit type, n (%)
 ED revisit 6 (30.0) 15 (26.8)
 Readmitted 14 (70.0) 41 (73.2)
Female sex, n (%) 12 (60.0) 30 (53.6) 0.79
Age in years, median (IQR) 66 (54–80) 67 (54–78) 0.81
Length of stay in days, median (IQR) 6 (3–15) 8 (3–14) 0.96
ICU admission, n (%) 8 (40.0) 20 (35.7) 0.79
Days to revisit, median (IQR) 6 (2–13) 9 (3–19) 0.10
Limited English proficiency, n (%) 5 (25.0) 12 (21.4) 0.76
Discharge location 0.31
 Extended care facility 7 (35.0) 24 (42.9)
 Home 4 (20.0) 17 (30.4)
 Home with services 9 (45.0) 15 (26.8)
Race/ethnicity,*n (%) 0.26
 Black 8 (42.1) 13 (23.6)
 Hispanic/Latino 2 (10.5) 12 (21.8)
 White, non-Hispanic 9 (47.4) 26 (47.2)
 Other 0 (0) 4 (7.3)
Comorbidities,n (%)
 Congestive heart failure 3 (15.0) 11 (20.0) 0.75
 Chronic lung disease 4 (20.0) 20 (36.4) 0.26
 Diabetes 9 (45.0) 20 (36.4) 0.59
 Liver disease 3 (15.0) 5 (9.1) 0.43
 Malignancy 0 (0) 1 (1.8) 1.00
 Obesity 2 (10.0) 13 (23.6) 0.33
 Alcohol and/or substance use disorders 1 (5.0) 2 (3.6) 1.00
 Hypertension 10 (50.0) 30 (54.5) 0.80
Elixhauser comorbidity readmission index score, median (IQR) 29 (16–31) 21 (11–38) 0.51
Fever 24 hours prior to discharge 3 (15.0) 3 (5.5) 0.18
Supplemental oxygen 24 hours prior to discharge 4 (20.0) 11 (20.0) 1.00
Discharge on supplemental oxygen 1 (5.0) 7 (12.7) 0.67
Follow-up arranged within 7 days from discharge 9 (69.2) 17 (53.1) 0.51

Race/ethnicity data were not available for two patients (one in each group).

Comorbidity data were not available for one patient in the nonpreventable group.

Follow-up arrangement was determined only for the patients discharged to home (with or without services).ED, emergency department;IQR, interquartile range.